APA

Wolf D., D'Haens G., Sandborn W. J., Colombel J., Van Assche G., Robinson A. M., Lazar A., Zhou Q., Petersson J. & Thakkar R. B. (20141014). Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis. : Alimentary pharmacology & therapeutics.

Chicago

Wolf D, D'Haens G, Sandborn W J, Colombel J-F, Van Assche G, Robinson A M, Lazar A, Zhou Q, Petersson J and Thakkar R B. 20141014. Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis. : Alimentary pharmacology & therapeutics.

Harvard

Wolf D., D'Haens G., Sandborn W. J., Colombel J., Van Assche G., Robinson A. M., Lazar A., Zhou Q., Petersson J. and Thakkar R. B. (20141014). Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis. : Alimentary pharmacology & therapeutics.

MLA

Wolf D, D'Haens G, Sandborn W J, Colombel J-F, Van Assche G, Robinson A M, Lazar A, Zhou Q, Petersson J and Thakkar R B. Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis. : Alimentary pharmacology & therapeutics. 20141014.